Mohammad Rashidian
Overview
Explore the profile of Mohammad Rashidian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
1689
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Cong M, Tavakolpour S, Berland L, Glockner H, Andreiuk B, Rakhshandehroo T, et al.
Bioconjug Chem
. 2021 Nov;
32(11):2397-2406.
PMID: 34748323
Site-specific protein labeling is important in biomedical research and biotechnology. While many methods allow site-specific protein modification, a straightforward approach for efficient N-terminal protein labeling is not available. We introduce...
12.
Islam A, Pishesha N, Harmand T, Heston H, Woodham A, Cheloha R, et al.
J Immunol
. 2021 Aug;
207(5):1468-1477.
PMID: 34408009
Immuno-positron emission tomography (PET), a noninvasive imaging modality, can provide a dynamic approach for longitudinal assessment of cell populations of interest. Transformation of mAbs into single-chain variable fragment (scFv)-based PET...
13.
Daneshpazhooh M, Tavakolpour S, Salehi Farid A, Ebadi M, Nili A, Rashidian M, et al.
Int J Dermatol
. 2021 Jun;
61(1):e14-e17.
PMID: 34156705
No abstract available.
14.
Berland L, Kim L, Abousaway O, Mines A, Mishra S, Clark L, et al.
Biomolecules
. 2021 Apr;
11(5).
PMID: 33925941
Recent advances in medical treatments have been revolutionary in shaping the management and treatment landscape of patients, notably cancer patients. Over the last decade, patients with diverse forms of locally...
15.
Teunissen A, Abousaway O, Munitz J, van Leent M, Toner Y, Priem B, et al.
STAR Protoc
. 2021 Apr;
2(2):100434.
PMID: 33899016
Noninvasive immunoimaging holds great potential for studying and stratifying disease as well as therapeutic efficacy. Radiolabeled single-domain antibody fragments (i.e., nanobodies) are appealing probes for immune landscape profiling, as they...
16.
Clayton K, Mylvaganam G, Villasmil-Ocando A, Stuart H, Maus M, Rashidian M, et al.
Cell Host Microbe
. 2021 Feb;
29(3):435-447.e9.
PMID: 33571449
Natural killer (NK) cells are innate cytolytic effectors that target HIV-infected CD4 T cells. In conjunction with antibodies recognizing the HIV envelope, NK cells also eliminate HIV-infected targets through antibody-dependent...
17.
Abousaway O, Rakhshandehroo T, Van Den Abbeele A, Kircher M, Rashidian M
Nanotheranostics
. 2021 Jan;
5(1):90-112.
PMID: 33391977
Immunotherapy has revolutionized the treatment of several malignancies. Notwithstanding the encouraging results, many patients do not respond to treatments. Evaluation of the efficacy of treatments is challenging and robust methods...
18.
Dongre A, Rashidian M, Eaton E, Reinhardt F, Thiru P, Zagorulya M, et al.
Cancer Discov
. 2020 Dec;
11(5):1286-1305.
PMID: 33328216
The epithelial-to-mesenchymal transition, which conveys epithelial (E) carcinoma cells to quasi-mesenchymal (qM) states, enables them to metastasize and acquire resistance to certain treatments. Murine tumors composed of qM mammary carcinoma...
19.
Priem B, van Leent M, Teunissen A, Sofias A, Mourits V, Willemsen L, et al.
Cell
. 2020 Oct;
183(3):786-801.e19.
PMID: 33125893
Trained immunity, a functional state of myeloid cells, has been proposed as a compelling immune-oncological target. Its efficient induction requires direct engagement of myeloid progenitors in the bone marrow. For...
20.
Woodham A, Zeigler S, Zeyang E, Kolifrath S, Cheloha R, Rashidian M, et al.
Nat Methods
. 2020 Sep;
17(10):1025-1032.
PMID: 32929269
The immune system's ability to recognize peptides on major histocompatibility molecules contributes to the eradication of cancers and pathogens. Tracking these responses in vivo could help evaluate the efficacy of...